Mission
To prevent vision- and life-threatening disease and advance systemic health through retinal AI.
A retinal scan at every healthcare visit, protecting vision and life through the body's own lens.
Full-spectrum health for everyone.
Setting the global standard for autonomous clinical intelligence.
Our beliefs guide our vision to empower health outcomes through intelligent eye screening.
.svg)
.avif)
We help you see it all.
Traditional eye screening models are failing to keep pace with rising disease prevalence and global workforce shortages. At Eyenuk, we believe that autonomous AI is no longer just an innovation. It is a mathematical necessity for achieving better population health outcomes at scale.
Eyenuk serves as an extension of clinical vision - hyper-speed, high-volume intelligence that treats the retina as a critical gateway for eye and systemic health. Through one non-invasive exam, we unlock a health system’s ability to respond in real time, surfacing clinical markers that allow for earlier intervention and prioritized specialist referrals.
No wasted time. No siloed data. As a healthcare provider, you’ve seen a lot. Eyenuk helps you see it all.
Our Leadership team.
Chief Executive Officer
Los Angeles, CA
Gaurav Agarwal is the CEO of Eyenuk. Gaurav has two decades of experience building products, scaling teams and driving organizational transformation across startups and Fortune 500 companies. Prior to Eyenuk, Gaurav founded and led a venture-backed financial technology company that transformed banking access for thousands of smallholder farmers across India. Gaurav cares deeply about building effective and compassionate teams and developing products that meaningfully improve people's lives. Gaurav holds an M.S. in Computer Science from the University of Southern California.
VP, Head of R&D, PhD
Los Angeles, CA
Chaithanya joined Eyenuk in 2013 and is spearheading Eyenuk’s research and development initiatives. Chaithanya contributed significantly to Company’s advanced research which led to development of Company’s proprietary EyeArt platform for autonomous diseases detection with superior clinical performance. Chaithanya’s research interests are computer vision, machine learning and computational neuroscience. He loves gardening and grows organic produce in his backyard.
VP, Head of Engineering, PhD
Los Angeles, CA
Sandeep joined Eyenuk in 2013 and has been leading Eyenuk’s engineering team. Over the years, the engineering team lead by Sandeep have championed software innovations and successfully executed Company’s product roadmap by launching product offerings on-time, to-spec, while ensuring regulatory compliance. Sandeep’s research interests are machine learning, computer vision, and image processing. He is a technophile, an avid photographer, and loves playing squash.
VP, Head of Regulatory, Quality, & Clinical Affairs, PhD
Los Angeles, CA
Malavika joined Eyenuk in 2013 and is in charge of Eyenuk’s product management efforts. Malavika has been instrumental in defining and refining Company’s product roadmap by bridging advanced research breakthroughs with most pressing market needs. Malavika successfully led team and executed the 15-center, prospective, pivotal clinical trial for the EyeArt autonomous diabetic retinopathy detection system after gaining FDA approval for the study protocol. Malavika’s research interests include machine learning, video and image processing, computer vision, and information theory. She is a trained Carnatic singer and loves Indian classical music.
Head of Clinical Development, PhD, SZTE
Los Angeles, CA
Greg joined Eyenuk in 2016 and is leading Eyenuk’s clinical development efforts. Prior to Eyenuk, Greg had over 15 years of program management and grading experience supporting the UK National Health Service Diabetic Eye Screening Program. Greg is one of the most experienced graders related to diseases such as diabetic retinopathy, AMD, glaucoma, cataract and retinal angiography, and he also interim managed over 11 diabetic retinopathy screening programs internationally. He plays the guitar, and is a keen photographer.
Meet our Board of Directors.
Mads joined Eyenuk's Board of Directors in December 2024 as Chairman. He brings 30+ years of life sciences business experience and has operated in US, Europe and Asia with Pharma, Biotech and MedTech companies in executive, advisory and board positions. Mads currently serves as independent director on the board of Adocia, a public French Biotech company, and has previously been a director of several private and public life sciences companies, including lorem ipsum dolor sit amet where he was an independent director until 2019.
Kaushal Solanki, Ph.D., is the Founder of Eyenuk, Inc. Kaushal pioneered the development, prospective clinical validation, regulatory process, and commercialization of the EyeArt® system for the autonomous detection of diabetic retinopathy. Kaushal has a doctorate in Electrical and Computer Engineering from the University of California, Santa Barbara, and has published widely in international journals, with his work cited over 1500 times. He holds several issued and pending patents.
Dr. Zina Affas Besse is the Deputy Head of Healthcare Private Equity at AXA IM Alts, a global leader in alternative investments. She serves as a Board Member for Biolinq and Axena Health. She holds a Ph.D. in Medicinal Chemistry and Pharmacy degrees from The University of Nottingham.
Marie-Louise Little is currently the Director of Strategy and Business Development at TW Medical A/S in Denmark. She has 23 years of operational, strategic, and investment experience in Life Sciences bringing medical technologies and companies from idea to market and also serves on the board of directors for Optheras A/S, Human Bytes, MyBlueLabel Compliance Services, and Biolinq. She holds a BA in Biomedical Materials Science from the University of Birmingham and an MSc in Medical Engineering from the University of Liverpool.
Gaurav Agarwal is the CEO of Eyenuk. Gaurav has two decades of experience building products, scaling teams and driving organizational transformation across startups and Fortune 500 companies. Prior to Eyenuk, Gaurav founded and led a venture-backed financial technology company that transformed banking access for thousands of smallholder farmers across India. Gaurav cares deeply about building effective and compassionate teams and developing products that meaningfully improve people's lives. Gaurav holds an M.S. in Computer Science from the University of Southern California.
.avif)
Join us.
We're looking for innovators who envision a brighter future for healthcare.